Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception.
In this work we have studied the influences of nicotinic agents on the antinociception of morphine in formalin test. Nicotine (0.001-0.1 mg/kg) induced antinociception in mice in a dose-dependent manner in the early phase of formalin test, and also potentiated the morphine effect. The nicotinic receptor antagonist, mecamylamine (0.5 mg/kg), but not hexamethonium decreased the antinociception induced by nicotine (0.1 mg/kg) in both phases. The muscarinic receptor antagonist atropine (5 and 10 mg/kg) also decreased the response of nicotine. Mecamylamine, hexamethonium or atropine did not alter morphine antinociceptive response, while naloxone decreased responses induced by nicotine or morphine. The antagonists by themselves did not elicit any response in formalin test, however, high does of mecamylamine tend to increase pain response. It is concluded that central cholinergic and opioid receptor mechanisms may be involved in nicotine-induced antinociception.
Zarrindast
M R
MR
Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Iran.
Pazouki
M
M
Nassiri-Rad
S
S
D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D017288:Pain Threshold / Q000187:drug effects* / Q000502:physiology; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011957:Receptors, Opioid / Q000187:drug effects*
D000701:Analgesics, Opioid; D018722:Nicotinic Agonists; D011950:Receptors, Cholinergic; D011957:Receptors, Opioid; D009538:Nicotine; D009020:Morphine